Last reviewed · How we verify
NCT06970327
Totally Laparoscopic Distal Gastrectomy VS Pylorus-Preserving Gastrectomy for Early Gastric Cancer in the Middle Stomach
trial in Gastrectomy in 95 participants. Completed in 1 March 2025.
1 March 2025
Quick facts
| Lead sponsor | Changzhi Medical College |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 95 |
| Start date | 1 January 2020 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across China |
Conditions studied
- Gastrectomy — all drugs for Gastrectomy →
Sponsor
Changzhi Medical College
Who can join
Adults 18 to 85, any sex, with Gastrectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
With the development of laparoscopic technology, the surgical treatment of early gastric cancer (EGC) has shifted towards minimally invasive, precise, and function-preserving strategies. Totally laparoscopic distal gastrectomy (TLDG) and totally laparoscopic pylorus-preserving gastrectomy (TLPPG) are minimally invasive procedures. However, there is a lack of systematic evidence to directly compare their efficacies. This study focuses on two fully laparoscopic techniques, TLDG and TLPPG, to address two key objectives: (1) whether TLPPG can avoid the long-term functional sequelae of TLDG while ensuring oncological safety, including complications (delayed gastric emptying, reflux, and dumping syndrome), postoperative quality of life (assessed via the PGSAS-37 scale), and survival outcomes; and (2) the balance between complications and survival in function-preserving surgery. The findings aim to provide critical technical parameters for individualized surgical decision-making in EGC.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06970327
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastrectomy
Currently open trials in the same condition.
- NCT06028737 — Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer · Phase 2, PHASE3 · recruiting
- NCT06810882 — Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy · NA · recruiting
- NCT06982768 — How Epigenetic Changes in hMLH1 Connect Lab Research With Diagnosis in Gastric Cancer · recruiting
- NCT06680362 — The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery · active not recruiting
- NCT07517432 — The UGIRA International Registry for RAMIG for Gastric Cancer · recruiting
Other Changzhi Medical College trials
Trials by the same sponsor.
- NCT06440837 — Effectiveness of Stress Self-management Health Education Based on IMB Theory Among Nursing Students · NA · not yet recruiting
- NCT06238141 — Expressive Writing on Stress-Related and Work-Related Outcomes Among Chinese Nursing Interns · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06970327 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Changzhi Medical College
- Last refreshed: 14 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06970327.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing